BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36557813)

  • 1. AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R.
    Li K; Song K; Hou Y; Tian Y; Wang H; Sun L; Li A; Zhang Y
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.
    Peng R; Zhang PF; Yang X; Wei CY; Huang XY; Cai JB; Lu JC; Gao C; Sun HX; Gao Q; Bai DS; Shi GM; Ke AW; Fan J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):113. PubMed ID: 30836988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression.
    Bie CQ; Liu XY; Cao MR; Huang QY; Tang HJ; Wang M; Cao GL; Yi TZ; Wu SL; Xu WJ; Tang SH
    Oncotarget; 2016 Nov; 7(48):79305-79318. PubMed ID: 27813495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop.
    Bie C; Chen Y; Tang H; Li Q; Zhong L; Peng X; Shi Y; Lin J; Lai J; Wu S; Tang S
    Dig Dis Sci; 2022 Feb; 67(2):569-584. PubMed ID: 33559791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircRNA_0008194 functions as a ceRNA to promote invasion of hepatocellular carcinoma via inhibiting miR-190a/AHNAK signaling pathway.
    Liu W; Pan Y; Zhu H; Zhou Y; Zhang H; Liu L; Liu Q; Ji G
    J Clin Lab Anal; 2022 Apr; 36(4):e24286. PubMed ID: 35199873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR-133a to regulate IGF-1R expression.
    Zhang W; Liu S; Liu K; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):5154-5164. PubMed ID: 31207081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
    Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H
    Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines.
    Zhao H; Desai V; Wang J; Epstein DM; Miglarese M; Buck E
    Mol Cancer Ther; 2012 Feb; 11(2):503-13. PubMed ID: 22161861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R.
    Ren L; Yao Y; Wang Y; Wang S
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31160483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
    Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
    Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-455-5p suppresses hepatocellular carcinoma cell growth and invasion via IGF-1R/AKT/GLUT1 pathway by targeting IGF-1R.
    Hu Y; Yang Z; Bao D; Ni JS; Lou J
    Pathol Res Pract; 2019 Dec; 215(12):152674. PubMed ID: 31732382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
    Tovar V; Alsinet C; Villanueva A; Hoshida Y; Chiang DY; Solé M; Thung S; Moyano S; Toffanin S; Mínguez B; Cabellos L; Peix J; Schwartz M; Mazzaferro V; Bruix J; Llovet JM
    J Hepatol; 2010 Apr; 52(4):550-9. PubMed ID: 20206398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression.
    Wang Y; Chen X; Yao N; Gong J; Cao Y; Su X; Feng X; Tao M
    J Gastrointest Oncol; 2022 Feb; 13(1):355-367. PubMed ID: 35284123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo CRISPR screen identifies LTN1 as a novel tumor suppressor ubiquitinating insulin-like growth factor 2 mRNA-binding protein 1 in hepatocellular carcinoma.
    Peng R; Cao J; Zhang C; Zhou J; Su BB; Tu DY; Jiang GQ; Jin SJ; Xu YP; Bai DS
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37708447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nogo-C contributes to HCC tumorigenesis via suppressing cell growth and its interactome analysis with comparative proteomics research.
    Liu X; Cui SJ; Zhu SJ; Geng DC; Yu L
    Int J Clin Exp Pathol; 2014; 7(5):2044-55. PubMed ID: 24966913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib.
    Desbois-Mouthon C; Cacheux W; Blivet-Van Eggelpoël MJ; Barbu V; Fartoux L; Poupon R; Housset C; Rosmorduc O
    Int J Cancer; 2006 Dec; 119(11):2557-66. PubMed ID: 16988945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.
    Zhang W; Liu K; Liu S; Ji B; Wang Y; Liu Y
    Tumour Biol; 2015 Dec; 36(12):9779-88. PubMed ID: 26156803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of insulin-like growth factor-1 receptor predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhang Z; Lei B; Chai W; Liu R; Li T
    Medicine (Baltimore); 2019 Nov; 98(44):e17680. PubMed ID: 31689787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.
    Xiao Y; Tian Q; He J; Huang M; Yang C; Gong L
    Onco Targets Ther; 2016; 9():3535-44. PubMed ID: 27366090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.
    Assal RA; El Tayebi HM; Hosny KA; Esmat G; Abdelaziz AI
    Mol Med Rep; 2015 Jul; 12(1):645-50. PubMed ID: 25739014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.